NewBridge Pharmaceuticals

Overview

This specialty pharmaceutical company, based in Dubai, United Arab Emirates, was founded in 2010 and operates primarily in the Middle East and North Africa (MENA) region. Its mission is to bridge the access gap for innovative therapies by focusing on in-licensing, acquiring, registering, and commercializing pharmaceutical and biologic products approved by authorities such as the U.S. FDA and EMA.

The organization addresses unmet medical needs across key therapeutic areas including cancer, diabetes, renal, and cardiovascular diseases. Through collaborations with global pharmaceutical and biotech companies, it introduces novel treatments to the MENA market, providing in-licensing, registration, marketing, and distribution services. Its strategic partnerships help enhance patient access to advanced therapies for improved healthcare outcomes in the region.

Basic Information

Contact Details

• Phone: +971 4 429 8700
• Website: nbpharma.com
• LinkedIn: linkedin.com/company/newbridge-pharmaceuticals

Key Focus Areas & Initiatives

• inlicense & commercialize fda or ema
• european approved innovative pharmaceutics
• biologics
• other healthcare solutions in the mena region
• oncology
• immunology
• neuroscience
• gastrointestinal
• nutrition
• pharmaceutical manufacturing
• hospital & health care
• biotechnology
• health, wellness & fitness
• pharmaceuticals
• medical

Technologies Used

• Bootstrap Framework
• CloudFlare Hosting
• Cloudflare DNS
• DynECT
• Google Tag Manager
• Mobile Friendly
• Outlook
• Shutterstock